LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fermi, Inc., (“Fermi” or the "Company") (NASDAQ: FRMI) investors off a class action on behalf of investors that bought securities between February 26, 2025 and August 4, 2025, inclusive (the “Class Period”). agilon investors have until March 2, 2026 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or ...

Thomas Goodhead, the co-founder of Pogust Goodhead, was ousted last summer amid allegations that he spent money intended for litigation on private jets and parties - Heathcliff O'Malley The class action law firm behind two of the biggest cases in the High Court has cast doubt over its future after losing almost £400m in two years. Pogust Goodhead, which is pursuing claims as part of the Dieselgate scandal, is facing a cash crunch as it battles a debt pile of £630m. The London-headquartered law firm lost ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Blue Owl Capital Inc. regarding a class action lawsuit due to alleged misleading statements and undisclosed liquidity issues during a specified class period [1][3]. Group 1: Allegations - The complaint alleges that Blue Owl was under significant pressure on its asset base from redemptions by business development companies [3]. - It is claimed that the company faced undisclosed liquidity issues as a result of these pressures [3]. - The lawsuit suggests that Blue Owl may limit or halt redemptions of certain business development companies due to these liquidity concerns [3]. - Defendants' positive statements about the company's business and prospects are alleged to be materially misleading and lack a reasonable basis [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as February 6, 2025, to November 16, 2025 [3]. - Shareholders are encouraged to register for the class action by February 2, 2026, to potentially be appointed as lead plaintiffs [4]. - There is no cost or obligation for shareholders to participate in the case, and they will receive updates through portfolio monitoring software [4]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Alexandria Real Estate Equities, Inc. regarding a federal securities class action lawsuit, with a lead plaintiff deadline set for January 26, 2026 [2][4]. Company Overview - Alexandria Real Estate Equities, Inc. (NYSE: ARE) is facing allegations of violating federal securities laws by making false or misleading statements about its Long Island City property and its leasing value as part of its Megacampus™ strategy [4]. Financial Performance - Alexandria reported third quarter earnings on October 27, 2025, which fell short of analyst expectations, showing a 5% decline in revenue and a 7% decline in adjusted funds from operation. The average occupancy rate also decreased from 94.8% in the previous year to 91.4% [5]. Stock Market Reaction - Following the release of disappointing financial results, Alexandria's stock price dropped over 19% on October 28, 2025 [5]. Legal Proceedings - The lawsuit allows any member of the putative class to move the Court to serve as lead plaintiff, with the lead plaintiff being the investor with the largest financial interest in the relief sought [6]. Call for Information - Faruqi & Faruqi encourages individuals with information regarding Alexandria's conduct, including whistleblowers and former employees, to come forward [7].

Core Viewpoint - The complaint against Baxter International alleges violations of federal securities laws due to misleading statements regarding the Novum LVP, which suffered systemic defects leading to serious patient risks [2]. Group 1: Allegations and Defects - The Novum LVP experienced systemic defects causing malfunctions such as underinfusion, overinfusion, and non-delivery of fluids, posing risks of serious injury or death to patients [2]. - Baxter was aware of multiple device malfunctions, injuries, and deaths related to these defects but failed to adequately address them [2]. - The company's attempts to remedy the situation through customer alerts were deemed insufficient as design flaws persisted, continuing to harm patients [2]. Group 2: Impact on Business Operations - Due to the defects, there was an increased risk that customers would be instructed to take existing Novum LVPs out of service, and Baxter would halt all new sales of these pumps [2]. - Baxter's statements regarding the safety, efficacy, product rollout, customer feedback, and sales prospects of the Novum LVPs were materially false and misleading [2]. Group 3: Market Reaction - The extent of the alleged fraud was revealed on July 31, 2025, when Baxter announced a voluntary and temporary pause in shipments and installations of the Novum LVP, leading to a 22.4% drop in stock price, closing at $21.76 on the same day [3].

NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask: Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. About Monteverde & Associates PC SOURCE Monteverde & Associates PC Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire S ...

Core Viewpoint - The case alleges that Sprouts' optimistic reports of growth and stability in the face of macroeconomic instability fell short of reality [1] Group 1 - Sprouts is facing allegations regarding the accuracy of its growth and stability reports [1]

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/dexcom-inc-loss-submission-form-2/?id=178599&from=3 CLASS PERIOD: January 8, 2024 to ...

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Perrigo business and prospects, resulting in its stock trading at inflated prices. ...

Core Insights - Perrigo Company plc is facing a class action lawsuit for investors who purchased securities between February 27, 2023, and November 4, 2025, with a deadline for filing a lead plaintiff motion set for January 16, 2026 [1][2] - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, which includes evaluating alternatives to enhance cash flows and reassessing a previously announced investment of $240 million in this sector [3] - Following the announcement of the strategic review, Perrigo's stock price dropped by $5.09, or 25.21%, closing at $15.10 per share on the same day [3] Legal Context - The Portnoy Law Firm is representing investors in claims related to corporate wrongdoing, emphasizing their experience in recovering over $5.5 billion for affected investors [4]